OUTLOOK THERAPEUTICS, INC. Finance Lease, Liability, Current
OUTLOOK THERAPEUTICS, INC. (OTLK) had Finance Lease, Liability, Current of $1.08 thousand as of 2023-12-31, per its 10-Q filed 2024-02-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt and Lease Obligation, Current
us-gaap:FinanceLeaseLiabilityCurrent · last filed 2024-12-27
- 2023-12-31: Finance Lease, Liability, Current $1.08K.
- 2023-09-30: Finance Lease, Liability, Current $4.27K.
- 2023-06-30: Finance Lease, Liability, Current $7.35K.
- 2023-03-31: Finance Lease, Liability, Current $10.33K.
| Period end | Finance Lease, Liability, Current |
|---|---|
| 2023-12-31 | $1.08K 10-Q · filed 2024-02-14 |
| 2023-09-30 | $4.27K 10-K · filed 2024-12-27 |
| 2023-06-30 | $7.35K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $10.33K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $12.14K 10-Q · filed 2023-02-14 |
| 2022-09-30 | $11.75K 10-K · filed 2023-12-22 |
| 2022-06-30 | $14.35K 10-Q · filed 2022-08-10 |
| 2022-03-31 | $18.42K 10-Q · filed 2022-05-13 |
| 2021-12-31 | $22.46K 10-Q · filed 2022-02-14 |
| 2021-09-30 | $26.46K 10-K · filed 2022-12-29 |
| 2021-06-30 | $27.46K 10-Q · filed 2021-08-13 |
| 2021-03-31 | $26.97K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $26.50K 10-Q · filed 2021-02-16 |
| 2020-09-30 | $29.78K 10-K · filed 2021-12-23 |
| 2020-06-30 | $41.21K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $52.85K 10-Q · filed 2020-05-15 |
| 2019-12-31 | $172.61K 10-Q · filed 2020-02-14 |
| 2019-09-30 | $192.29K 10-K · filed 2020-12-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |